Feasibility of Long-Term Proteasome Inhibition in Multiple Myeloma by In-Class Transition from Bortezomib to Ixazomib

Publication date: Available online 6 July 2020Source: Clinical Lymphoma Myeloma and LeukemiaAuthor(s): Sudhir Manda, Habte A. Yimer, Stephen J. Noga, Saulius Girnius, Christopher A. Yasenchak, Veena Charu, Roger Lyons, Jack Aiello, Kimberly Bogard, Renda H. Ferrari, Dasha Cherepanov, Brittany Demers, Vickie Lu, Presley Whidden, Suman Kambhampati, Ruemu E. Birhiray, Haresh S. Jhangiani, Ralph Boccia, Robert M. Rifkin
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research